Green Thumb Industries AI Stock Analysis
Want to see TSE:GTII full AI Analyst Report?
Green Thumb Industries (GTII) AI Stock Analysis
Green Thumb Industries
(CNQX:GTII)
The score is led by solid financial fundamentals (profitability, manageable leverage, and strong operating/free cash flow) and a relatively modest P/E valuation. These positives are tempered by weaker technical momentum (below key moving averages with negative MACD) and earnings-call risks centered on continued pricing pressure, near-term revenue softness, and regulatory/tax uncertainty.
Green Thumb Industries (GTII) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 1.32B
- Dividend Yield
- ―
- Average Volume (3M)
- 154.64K
- Price to Earnings (P/E)
- 14.2
- Beta (1Y)
- 1.19
- Revenue Growth
- 6.44%
- EPS Growth
- 127.50%
- Country
- Canada
- Employees
- 5,000
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Drug Manufacturers - Specialty & Generic
Green Thumb Industries Business Overview & Revenue Model
Company Description
Green Thumb Industries Inc. is a U.S.-based company focused on the cultivation, processing, and distribution of cannabis products for both medicinal and adult recreational consumption. Its diverse product portfolio includes raw cannabis flower and a...
How the Company Makes Money
GTII primarily makes money by selling cannabis and cannabis-derived products through two main channels: (1) retail sales through company-owned dispensaries and (2) wholesale sales of branded products to other dispensaries and retail operators. In ret...
Green Thumb Industries Earnings Call Summary
The call was predominantly positive: Green Thumb delivered double-digit revenue growth, positive same-store sales, higher normalized EBITDA, strong operating cash flow, brand leadership, and continued expansion supported by a substantial cash balance. However, management emphasized persistent pricing pressure, a stressed consumer, lower reported gross margin, higher operating costs, a GAAP net loss, uncertain federal and hemp policy, and possible continued tax liabilities. The positive operating performance and strategic positioning outweighed the stated challenges.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Green Thumb expects full-year 2026 CapEx of approximately $80 million, excluding real estate purchases; fourth quarter sequential revenue is expected to be flat to down slightly due to the pricing environment, with some continued compression expected in the coming quarters. The company expects to open anywhere between three and five additional stores in Florida between now and the end of the year, and over the next 12 to 16 months anticipates 10 plus stores in Florida and one or two in Ohio, while Texas remains the big unknown. Virginia adult-use sales are scheduled to begin July 1st, 2027, and the company’s guess is that it could take anywhere from 12 to 24 to maybe 36 months before there is enough capacity in the state to absorb the potential demand.
Green Thumb Industries Financial Statement Overview
Summary
Strong TTM revenue growth (~273%) with healthy profitability (gross margin ~44.9%, net margin ~10.6%) and meaningful positive operating cash flow (~$253M) and free cash flow (~$180M). Offsetting this, margins have compressed versus prior peaks (EBIT margin down vs 2024) and free cash flow declined versus 2025 with a history of volatility, while returns remain mid-single-digit (ROE ~6.8%).
Income Statement
78PositiveBalance Sheet
74PositiveCash Flow
70Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.24B | 1.20B | 1.14B | 1.05B | 1.02B | 893.56M |
| Gross Profit | 545.47M | 548.94M | 601.11M | 526.50M | 503.96M | 491.93M |
| EBITDA | 319.12M | 337.13M | 392.00M | 324.14M | 270.28M | 329.53M |
| Net Income | 99.68M | 116.15M | 73.08M | 36.27M | 11.98M | 75.44M |
Balance Sheet | ||||||
| Total Assets | 2.85B | 2.78B | 2.54B | 2.49B | 2.43B | 2.39B |
| Cash, Cash Equivalents and Short-Term Investments | 316.00M | 284.76M | 171.69M | 161.63M | 177.68M | 230.42M |
| Total Debt | 554.50M | 518.35M | 530.70M | 570.28M | 535.86M | 431.69M |
| Total Liabilities | 986.36M | 877.81M | 747.93M | 786.80M | 768.10M | 766.37M |
| Stockholders Equity | 1.86B | 1.90B | 1.79B | 1.70B | 1.67B | 1.62B |
Cash Flow | ||||||
| Free Cash Flow | 179.51M | 217.60M | 115.00M | 4.93M | -20.94M | -55.80M |
| Operating Cash Flow | 253.40M | 300.09M | 195.18M | 224.97M | 158.56M | 132.05M |
| Investing Cash Flow | -92.81M | -132.67M | -89.54M | -227.91M | -219.95M | -280.73M |
| Financing Cash Flow | -80.17M | -51.83M | -95.59M | -13.11M | 8.64M | 295.34M |
Green Thumb Industries Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GTII, the sentiment is Negative. The current price of 8.64 is below the 20-day moving average (MA) of 9.03, below the 50-day MA of 9.62, and below the 200-day MA of 9.87, indicating a bearish trend. The MACD of -0.16 indicates Negative momentum. The RSI at 41.89 is Neutral, neither overbought nor oversold. The STOCH value of 10.90 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:GTII.
Green Thumb Industries Risk Analysis
Green Thumb Industries disclosed 67 risk factors in its most recent earnings report. Green Thumb Industries reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksGreen Thumb Industries Peers Comparison
Overall Rating
TSE:GTII69Neutral
TSE:CURA52Neutral
TSE:VRNO51Neutral
TSE:JUSH49Neutral
TSE:CL45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | CAD 1.89B | 14.17 | 5.30% | ― | 6.44% | 127.50% | |
| 52Neutral | CAD 3.07B | -223.82 | -1.47% | ― | 5.01% | 92.12% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | CAD 2.17B | -1.31 | -30.11% | ― | 0.61% | 37.92% | |
| 49Neutral | CAD 109.84M | -1.40 | 40.14% | ― | 5.37% | 17.78% | |
| 45Neutral | CAD 328.01M | -1.75 | -28.54% | ― | -2.43% | -80.34% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:GTII | Green Thumb Industries (OTC) | 8.64 | 1.11 | 14.74% | |
| TSE:JUSH | Jushi Holdings Inc | 0.55 | 0.00 | 0.00% | |
| TSE:CURA | Curaleaf Holdings (Otc) | 11.41 | 3.34 | 41.39% | |
| TSE:CL | Cresco Labs OTC | 0.71 | -0.28 | -28.28% | |
| TSE:VRNO | Verano Holdings Corp. | 6.32 | 0.00 | 0.00% |
Green Thumb Industries Corporate Events
Green Thumb Extends $50 Million Share Buyback in Cannabis Market Confidence Play
PositiveGreen Thumb Industries has authorized the continuation of its share repurchase program for another 12 months, allowing up to $50 million in subordinate voting share buybacks. The cannabis CPG and retail operator previously repurchased about 29.5 mill...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026
